Skip to main content

Table 2 Targeted malaria elimination studies in the greater Mekong Subregion Q2 2015

From: Malaria eradication and elimination: views on how to translate a vision into reality

Country

Start

Drugs

Rounds

Endpoint

Number of villages

Thai Myanmar border Phase 1

Q2 2013

DHA – piperaquine + PQa

3

Parasite prevalenceb

4

Thai Myanmar border Phase 2

Q4 2014

DHA – piperaquine + PQa

3

Parasite prevalenceb

300

Vietnam

Q4 2013

DHA – piperaquine + PQa

3

Parasite prevalenceb

4

Cambodia - Battambang

Q2 2015

DHA - piperaquine

3

Parasite prevalenceb

4

Cambodia - Preah Vihear

Q2 2015

DHA - piperaquine

3

Parasite prevalenceb

8

Laos - Savannakhet

Q1 2016

DHA – piperaquine + PQa

3

Parasite prevalenceb

4

Myanmar

Q1 2015

DHA – piperaquine + PQa

3

Parasite prevalenceb

8

  1. PQ piperaquine
  2. aSingle low dose primaquine (15 mg)
  3. bParasite prevalence determined by high volume ultra-sensitive qPCR